Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
Biorxiv : the Preprint Server for Biology
|
June 12, 2025
Multiscale Modeling Uncovers Macrophage Infiltration and TNF-α Signaling Networks for Targeting in Inflammatory Breast Cancer Tumor Emboli
Pritha Pai, Christophe Van Berckelaer, Steven Van Laere, et al.
Gastro Hep Advances
|
January 26, 2026
Iron Deficiency Anemia is Associated With Gastric Intestinal Metaplasia in Patients With <i>Helicobacter pylori</i> Infection
Serach Patterson, Jacqueline Emerson, HannahSofia Brown, et al.
Research Square
|
November 14, 2023
Mediator Kinase Inhibition Impedes Transcriptional Plasticity and Prevents Resistance to ERK/MAPK-Targeted Therapy in KRAS-Mutant Cancers
Kris Wood, Daniel Nussbaum, Colin Martz, et al.
Clinical Genitourinary Cancer
|
June 3, 2020
PD-L1 Assay Concordance in Metastatic Renal Cell Carcinoma and Metastatic Urothelial Carcinoma
Landon C Brown, Jason Zhu, Matthew K Labriola, et al.
Biopreservation and Biobanking
|
November 9, 2020
Biobanking in the COVID-19 Era and Beyond: Part 1. How Early Experiences Can Translate into Actionable Wisdom
Clare M Allocca, Marianna J Bledsoe, Monique Albert, et al.
Investigational New Drugs
|
November 1, 2013
Phase I study of dasatinib in combination with capecitabine, oxaliplatin and bevacizumab followed by an expanded cohort in previously untreated metastatic colorectal cancer
John H Strickler, Shannon McCall, Andrew B Nixon, et al.
Journal for Immunotherapy of Cancer
|
October 17, 2022
Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor response in metastatic renal cell carcinoma
Landon C Brown, Jason Zhu, Kunal Desai, et al.
Journal of Cancer
|
July 12, 2019
Perspectives on Inflammatory Breast Cancer (IBC) Research, Clinical Management and Community Engagement from the Duke IBC Consortium
Gayathri R Devi, Holly Hough, Nadine Barrett, et al.
Oncoimmunology
|
September 14, 2020
Proliferative potential and response to nivolumab in clear cell renal cell carcinoma patients
Tian Zhang, Sarabjot Pabla, Felicia L Lenzo, et al.
Cell Stem Cell
|
May 4, 2022
Patient-derived micro-organospheres enable clinical precision oncology
Shengli Ding, Carolyn Hsu, Zhaohui Wang, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
Biorxiv : the Preprint Server for Biology
|
June 12, 2025
Multiscale Modeling Uncovers Macrophage Infiltration and TNF-α Signaling Networks for Targeting in Inflammatory Breast Cancer Tumor Emboli
Pritha Pai, Christophe Van Berckelaer, Steven Van Laere, et al.
Gastro Hep Advances
|
January 26, 2026
Iron Deficiency Anemia is Associated With Gastric Intestinal Metaplasia in Patients With <i>Helicobacter pylori</i> Infection
Serach Patterson, Jacqueline Emerson, HannahSofia Brown, et al.
Research Square
|
November 14, 2023
Mediator Kinase Inhibition Impedes Transcriptional Plasticity and Prevents Resistance to ERK/MAPK-Targeted Therapy in KRAS-Mutant Cancers
Kris Wood, Daniel Nussbaum, Colin Martz, et al.
Clinical Genitourinary Cancer
|
June 3, 2020
PD-L1 Assay Concordance in Metastatic Renal Cell Carcinoma and Metastatic Urothelial Carcinoma
Landon C Brown, Jason Zhu, Matthew K Labriola, et al.
Biopreservation and Biobanking
|
November 9, 2020
Biobanking in the COVID-19 Era and Beyond: Part 1. How Early Experiences Can Translate into Actionable Wisdom
Clare M Allocca, Marianna J Bledsoe, Monique Albert, et al.
Investigational New Drugs
|
November 1, 2013
Phase I study of dasatinib in combination with capecitabine, oxaliplatin and bevacizumab followed by an expanded cohort in previously untreated metastatic colorectal cancer
John H Strickler, Shannon McCall, Andrew B Nixon, et al.
Journal for Immunotherapy of Cancer
|
October 17, 2022
Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor response in metastatic renal cell carcinoma
Landon C Brown, Jason Zhu, Kunal Desai, et al.
Journal of Cancer
|
July 12, 2019
Perspectives on Inflammatory Breast Cancer (IBC) Research, Clinical Management and Community Engagement from the Duke IBC Consortium
Gayathri R Devi, Holly Hough, Nadine Barrett, et al.
Oncoimmunology
|
September 14, 2020
Proliferative potential and response to nivolumab in clear cell renal cell carcinoma patients
Tian Zhang, Sarabjot Pabla, Felicia L Lenzo, et al.
Cell Stem Cell
|
May 4, 2022
Patient-derived micro-organospheres enable clinical precision oncology
Shengli Ding, Carolyn Hsu, Zhaohui Wang, et al.
Page
of 4